A trio of aging-focused biotechs and research firms formed a joint venture to develop small molecules for a novel target hoping to extend life spans.

Profusa raised more than $45 million in a series C round for its tissue-integrated biosensors.

Medtronic’s new patient engagement program aims to use game-design elements to encourage diabetes patients to better track their blood glucose levels.

GN Hearing unveiled the first in a new category of its ReSound LiNX 3D line of hearing aids, which it dubs as “premium-plus,” at a higher price point.

Adherium launched its digital inhaler add-on in the U.S., following a recent 510(k) clearance allowing it to sell the devices directly to consumers.

Former Fierce 15 winner MaxQ plans to go public with $8 million IPO, as it awaits FDA approval of its AI tech for analyzing CT scans for brain bleeds.

Senseonics’ long-term CGM is now available in clinics across the U.S. and has secured its first commercial payer.

Akili brought its series C total up to $68 million while it awaits an FDA decision on its prescription video game for pediatric ADHD.